| 000 | 01620 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515103826.0 | ||
| 264 | 0 | _c20080605 | |
| 008 | 200806s 0 0 eng d | ||
| 022 | _a0012-4486 | ||
| 024 | 7 |
_a10.1007/s10633-007-9110-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoschos, Marilita M | |
| 245 | 0 | 0 |
_aIntraocular bevacizumab for macular edema due to CRVO. A multifocal-ERG and OCT study. _h[electronic resource] |
| 260 |
_bDocumenta ophthalmologica. Advances in ophthalmology _cMar 2008 |
||
| 300 |
_a147-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 | _aBevacizumab |
| 650 | 0 | 4 | _aElectroretinography |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluorescein Angiography |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections |
| 650 | 0 | 4 | _aIntraocular Pressure |
| 650 | 0 | 4 |
_aMacular Edema _xdiagnosis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRetinal Vein Occlusion _xcomplications |
| 650 | 0 | 4 | _aTomography, Optical Coherence |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
| 650 | 0 | 4 | _aVisual Acuity |
| 650 | 0 | 4 | _aVitreous Body |
| 700 | 1 | _aMoschos, Michael | |
| 773 | 0 |
_tDocumenta ophthalmologica. Advances in ophthalmology _gvol. 116 _gno. 2 _gp. 147-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10633-007-9110-9 _zAvailable from publisher's website |
| 999 |
_c17698457 _d17698457 |
||